BiotechTube
Home/GlioCure/Louis-Marie Bachelot
LB

Louis-Marie Bachelot

President & CEO

GlioCure

Therapeutic Areas

Neuro-oncologyOncology

GlioCure Pipeline

DrugIndicationPhase
GC01.1Glioblastoma and other βIII-tubulin overexpressing solid tumorsPreclinical

Leadership Team at GlioCure

CL
Claire Lépinoux-Chambaud, PhD
Director of Research
View full GlioCure profile